{"id":"https://openalex.org/W2284685264","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.4656","title":"A phase I study of estramustine, weekly docetaxel and carboplatin (EDC) chemotherapy in patients with hormone refractory prostate cancer (HRPC)","display_name":"A phase I study of estramustine, weekly docetaxel and carboplatin (EDC) chemotherapy in patients with hormone refractory prostate cancer (HRPC)","publication_year":2004,"publication_date":"2004-07-15","ids":{"openalex":"https://openalex.org/W2284685264","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.4656","mag":"2284685264"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.22.14_suppl.4656","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.4656","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.4656","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078027978","display_name":"William K. Oh","orcid":"https://orcid.org/0000-0001-5113-8147","observed_orcids":["https://orcid.org/0000-0001-5113-8147"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. K. Oh","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I4210117453","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001377508","display_name":"E. Hagmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Hagmann","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I4210117453","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045746656","display_name":"Judith B. Manola","orcid":"https://orcid.org/0000-0001-6486-7998","observed_orcids":["https://orcid.org/0000-0001-6486-7998"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Manola","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I4210117453","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020223699","display_name":"Daniel J. George","orcid":"https://orcid.org/0000-0003-1499-7203","observed_orcids":["https://orcid.org/0000-0003-1499-7203","https://orcid.org/0000-0002-0836-8542"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. J. George","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I4210117453","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024482335","display_name":"Timothy D. Gilligan","orcid":"https://orcid.org/0000-0003-2308-9303","observed_orcids":["https://orcid.org/0000-0003-2308-9303"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. D. Gilligan","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I4210117453","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089854184","display_name":"Mitchell Reed Smith","orcid":"https://orcid.org/0000-0003-1428-8765","observed_orcids":["https://orcid.org/0000-0003-1428-8765"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. R. Smith","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I4210117453","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106084072","display_name":"Donald S. Kaufman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. S. Kaufman","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I4210117453","https://openalex.org/I4210126298"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056766924","display_name":"Philip W. Kantoff","orcid":"https://orcid.org/0000-0001-7275-0597","observed_orcids":["https://orcid.org/0000-0001-7275-0597"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. W. Kantoff","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Duke University Medical Center, Durham, NC; Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I4210117453","https://openalex.org/I4210126298"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"14_suppl","first_page":"4656","last_page":"4656"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9430000185966492},{"id":"https://openalex.org/keywords/estramustine","display_name":"estramustine","score":0.949999988079071},{"id":"https://openalex.org/keywords/weekly-docetaxel","display_name":"weekly docetaxel","score":0.9520000219345093},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":1.0},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9559999704360962},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8019999861717224},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.9670000076293945},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7960000038146973},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9890000224113464},{"id":"https://openalex.org/keywords/psa-response","display_name":"PSA response","score":0.828000009059906},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5329999923706055},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.4410000145435333},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.3499999940395355},{"id":"https://openalex.org/keywords/partial-response","display_name":"partial response","score":0.6060000061988831},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.44600000977516174}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.9613441228866577},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9171086549758911},{"id":"https://openalex.org/C2780201970","wikidata":"https://www.wikidata.org/wiki/Q412939","display_name":"Estramustine","level":5,"score":0.8886111974716187},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.8279176950454712},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7728525400161743},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6640564799308777},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5441537499427795},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.48958620429039},{"id":"https://openalex.org/C2781064554","wikidata":"https://www.wikidata.org/wiki/Q407883","display_name":"Ketoconazole","level":3,"score":0.4381941854953766},{"id":"https://openalex.org/C2780923524","wikidata":"https://www.wikidata.org/wiki/Q239426","display_name":"Mitoxantrone","level":3,"score":0.41632384061813354},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.406948059797287},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.40032368898391724},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3972305655479431},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3418115973472595},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.20151227712631226},{"id":"https://openalex.org/C2994223898","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate disease","level":4,"score":0.0},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.0},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.22.14_suppl.4656","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.4656","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.4656","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"doi:10.1200/jco.2004.22.90140.4656","doi":"https://doi.org/10.1200/jco.2004.22.90140.4656","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.90140.4656","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1563130062","https://openalex.org/W2589513617","https://openalex.org/W2131039431","https://openalex.org/W2264938055","https://openalex.org/W2082245048","https://openalex.org/W2590453764","https://openalex.org/W1971032648","https://openalex.org/W432702446","https://openalex.org/W2123127226","https://openalex.org/W2048946840"],"abstract_inverted_index":{"4656":[0],"Background:":[1],"The":[2,273],"purpose":[3],"of":[4,15,26,59,67,72,114,126,130,152,240,278,295],"this":[5,167,198],"study":[6],"was":[7,39,138,143,164,254,270],"to":[8],"define":[9],"the":[10,24,146,224,298],"maximal":[11],"tolerated":[12],"dose":[13,128,141,148,168,199,277,309],"(MTD)":[14],"weekly":[16,60],"docetaxel":[17,61,147,279],"combined":[18,283],"with":[19,28,32,50,245,284],"carboplatin":[20,83],"and":[21,43,82,119,179,187,202,209,262,286],"estramustine":[22,73,285],"in":[23,221,234,265,293],"treatment":[25],"patients":[27,47,121,157,189,195,204,244,296],"HRPC.":[29,266],"Methods:":[30],"Patients":[31],"progressive":[33],"HRPC":[34],"were":[35,48,89,122,134,158,232,291,305],"eligible.":[36],"Prior":[37,107],"chemotherapy":[38],"allowed,":[40],"except":[41],"taxanes":[42],"platinum":[44],"drugs.":[45],"25":[46],"treated":[49,123,196,215],"escalating":[51],"doses":[52],"(20,":[53],"25,":[54],"30,":[55],"36,":[56],"43":[57,281],"mg/m2)":[58,150],"on":[62,86],"days":[63,78],"2,":[64],"9,":[65],"16":[66],"a":[68,249,260],"28-day":[69],"cycle.":[70],"Doses":[71],"[140":[74],"mg":[75],"po":[76],"TID":[77],"1\u20135,":[79],"8\u201312,":[80],"15\u201319]":[81],"[AUC":[84],"(5)":[85],"day":[87],"2]":[88],"fixed.":[90],"Results:":[91],"Patient":[92],"characteristics:":[93],"median":[94,103],"age":[95],"64":[96],"yrs,":[97],"PS":[98],"0":[99],"(33%),":[100],"1":[101,171],"(66%),":[102],"PSA":[104,217,229,288],"117":[105],"ng/ml.":[106],"ketoconazole":[108],"(53%),":[109],"mitoxantrone":[110],"(10%).":[111],"A":[112],"total":[113,243],"3,":[115,116,117],"4":[118,185,191,203,210],"12":[120,194],"at":[124,145,197,297,307],"each":[125,173],"5":[127],"levels":[129],"docetaxel.":[131],"No":[132,160],"DLTs":[133],"noted.":[135],"Though":[136],"MTD":[137],"not":[139],"reached,":[140],"escalation":[142],"stopped":[144],"(43":[149],"because":[151],"significant":[153],"activity;":[154],"9":[155],"additional":[156],"accrued.":[159],"grade":[161,175,184,190,207],"3/4":[162,268],"myelosuppression":[163],"seen":[165,233,292,306],"until":[166],"level,":[169,200],"when":[170],"patient":[172,182],"developed":[174,183],"3":[176,208,239],"anemia,":[177],"neutropenia":[178],"thrombocytopenia.":[180],"One":[181],"thrombocytopenia":[186],"two":[188],"neutropenia.":[192],"Of":[193],"7":[201],"had":[205,248],"maximum":[206],"toxicities,":[211],"respectively.":[212],"Among":[213],"all":[214],"patients,":[216],"declines":[218,230,289],"\u226550%":[219,231,290],"occurred":[220],"60%.":[222],"At":[223],"recommended":[225,274,299],"phase":[226,275,300],"II":[227,276,301],"dose,":[228,302],"75%":[235,294],"(95%":[236],"C.I.,":[237],"43\u201395%).":[238],"14":[241],"(21%)":[242],"measurable":[246],"disease":[247],"partial":[250],"response.":[251],"Median":[252],"survival":[253],"14.6":[255],"months.":[256],"Conclusions:":[257],"EDC":[258],"is":[259,280],"well-tolerated":[261],"active":[263],"regimen":[264],"Grade":[267],"toxicity":[269],"primarily":[271],"myelosuppression.":[272],"mg/m2":[282],"carboplatin.":[287],"though":[303],"responses":[304],"every":[308],"level.":[310],"Author":[311],"Disclosure":[312],"Employment":[313],"or":[314,317],"Leadership":[315],"Consultant":[316],"Advisory":[318],"Stock":[319],"Ownership":[320],"Honoraria":[321],"Research":[322],"Funding":[323],"Expert":[324],"Testimony":[325],"Other":[326],"Remuneration":[327],"Aventis":[328]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}